CD226:CD155 Homogeneous Assay Kit
Catalog #
72052
$335
*
●
●
Purchase
Description
The CD226:CD155 Homogeneous Assay Kit is designed to measure the inhibition of CD226 binding to CD155 (PVR). The CD226:CD155 Homogeneous Assay Kit comes in a convenient AlphaLISA® format with purified biotinylated CD226, His-tagged CD155, and assay buffer to perform a total of 384 reactions. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CD226 and an inhibitor of choice is incubated with the CD155 for 60 minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.
●
Synonyms
PVR, NECL-5, CD155-His
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Format
Catalog Number |
Component |
Amount |
Storage |
|
71253 | CD226-Fc-biotin | 2 x 8 µg | -80°C | Avoid freeze/ thaw cycles! |
71181 | CD155-His | 2 x 8 µg | -80°C | |
79311 | 3x Immuno Buffer 1 | 4 ml | -20°C |
UniProt #
CD226: Q15762; CD155: P15151
Background
CD226 is an activating receptor expressed on the surface of natural killer (NK)
cells, monocytes, platelets, and T cells. Its natural ligands are CD112 and CD155 which are
expressed by antigen presenting cells (APC). Binding of CD226 to either CD112 or CD155
triggers NK cell effector function and can promote Th1 cell differentiation in T cells. CD226
competes for binding with CD112 and CD155 with the co-inhibitory receptor TIGIT. Agonistic
CD226 monoclonal antibodies are being explored as potential therapeutics in settings where
immune activation is beneficial, such as cancer.
References
1. Bottino, C. et al., J. Exp. Med. 2003; 198(4): 557-567.
2. Pende, D. et al., Blood. 2005; 105(5): 2066-2073.
2. Pende, D. et al., Blood. 2005; 105(5): 2066-2073.